Meliane

Ethinylestradiol and Gestodene, the active ingredients in Meliane, are a combined oral contraceptive presented as an oral tablet for oral use. It prevents unintended pregnancy in women of reproductive age by inhibiting ovulation and altering cervical mucus and endometrial lining.

GNH USA supplies Meliane as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable global distribution.

Meliane, a combined oral contraceptive, is used to prevent pregnancy and manage hormone‑related menstrual conditions.

Contraception: Prevents unintended pregnancy in women of childbearing potential when taken daily. Menstrual cycle regulation: Helps achieve more regular and predictable menstrual bleeding patterns. Acne management: Reduces androgen‑driven acne in some women as an additional benefit of hormonal regulation.

Meliane may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Nausea - Headache - Breast tenderness - Irregular vaginal bleeding

Serious or Rare Side Effects: - Deep vein thrombosis or pulmonary embolism - Hepatic adenoma or benign liver tumor - Severe allergic reaction (anaphylaxis)

Before prescribing Meliane, consider the following precautions. - Smoking: Women who smoke and are over 35 years should avoid use due to increased cardiovascular risk. - Cardiovascular disease: Do not use in patients with a history of myocardial infarction, stroke, or uncontrolled hypertension. - Liver disease: Use with caution in patients with active liver disease or hepatic impairment. - Pregnancy: Contraindicated in pregnancy; discontinue immediately if pregnancy occurs. - Store at ambient temperature: Keep below 25 °C, in the original packaging, protected from moisture and light.

Meliane can interact with several medicines; review patient medication lists carefully.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): May reduce efficacy of the oral contraceptive, increasing risk of pregnancy. - Enzyme inducers (e.g., rifampicin, carbamazepine, phenytoin): Significantly lower plasma levels of ethinylestradiol and gestodene, compromising contraceptive effect.

Moderate Interactions (Monitor Closely): - Antiretrovirals (e.g., protease inhibitors): May increase hormone concentrations, requiring monitoring for side effects. - Antifungals (e.g., ketoconazole): Can raise estrogen levels, potentially enhancing adverse effects. - Herbal supplements (e.g., St. John’s Wort): May modestly decrease contraceptive efficacy; advise consistent use of backup methods.